Stock screener

PHIO

Conviction 14HealthcareScan · Mon, Aug 10, 2026
PHIO$1.08+3.85%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 105.98K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Phio Pharmaceuticals Corp.PHARMACEUTICAL PREPARATIONSwww.phiopharma.com
Price1.08
Change+3.85%
Gap-0.96%
Rel volume0.00×
Avg volume1.53M
Avg $ vol1.39M
SMA 201.04
SMA 501.05
SMA 2001.19
Price vs 50+3.29%
Price vs 200-9.04%
MA stackmixed
50/200 cross
Supertrendup · 0.8795
RSI (14)55
MACD hist0.01
MACD crossbull · 7d
Stoch %K / %D72 / 59
ADX (14)13
+DI / −DI18 / 19
RSI divergence
MACD divergence
ATR %+6.09%
ADR %7.15%
52w high2.48
52w low0.8568
From 52w high-56.45%
Above 52w low+26.05%
New 52w highNo
SqueezeOff
Bollinger width17.87%
%B0.72
Donchian pos80.00%
Donchian high1.14
Donchian low0.8400
AVWAP (52w high)1.71
vs AVWAP high-36.98%
AVWAP (52w low)1.23
vs AVWAP low-12.38%
OBV trendDown
Chaikin MF (20)-0.33
Today vs 20d0.00×
Avg vol (14d)105.98K
Avg vol (20d)1.53M
Avg $ vol (20d)1.39M
Market cap12.55M
RS 3m (vs SPY)-14.47%
RS 6m (vs SPY)+7.27%
RS line new highNo
Trend template1/8
Technical rank58.7
1 week+4.85%
1 month+5.88%
3 months+0.93%
6 months+17.38%
1 year-52.00%
YTD-0.92%
P/E-1.44
P/B1.00
P/S
P/FCF-1.57
EPS-9.08
Div yield
ROE-69.02%
ROA-60.80%
Debt/Eq0.00
Current11.86
EV/EBITDA0.05
Gross margin
Net margin
Rev growth-100.00%
EPS growth-21.65%
Price target
Target upside
Analyst rating
Institutional
Ent. value-449.37K
Revenue0
Net income-4.14M
Gross profit
Free cash flow-7.99M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out
Employees6
ListedThu, May 10, 2012
Free float11.52M
Float %99.1%
Short interest177.62K
Days to cover0.1d
Short volume62.7%
Squeeze score19 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction14 / 100
Pattern quality
Tech rank58.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance1.13
Support0.8953
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PHIO

All disclosures →
No recent disclosed trades by Congress in PHIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHIO · 1 buy

InsiderSideShares
Bitterman Robert J
Chairman, Pres. & CEO · Common Stock, $.0001 par value · 2026-06-26
Buy10K

SEC filings

EDGAR filings in PHIO · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.